CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 443 filers reported holding CRISPR THERAPEUTICS AG in Q4 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,390,523 | -10.9% | 184,854 | +10.3% | 0.02% | -10.0% |
Q2 2023 | $9,412,922 | +21.6% | 167,596 | -2.1% | 0.02% | +11.1% |
Q1 2023 | $7,741,882 | +16.4% | 171,167 | +4.6% | 0.02% | +5.9% |
Q4 2022 | $6,650,422 | -39.7% | 163,602 | -3.1% | 0.02% | -43.3% |
Q3 2022 | $11,029,000 | +22.7% | 168,775 | +14.1% | 0.03% | +30.4% |
Q2 2022 | $8,991,000 | -32.0% | 147,946 | -29.8% | 0.02% | +64.3% |
Q1 2022 | $13,230,000 | +40.3% | 210,764 | +69.3% | 0.01% | -30.0% |
Q4 2021 | $9,432,000 | -4.9% | 124,477 | +40.4% | 0.02% | -20.0% |
Q3 2021 | $9,923,000 | -14.3% | 88,648 | +23.9% | 0.02% | -21.9% |
Q2 2021 | $11,580,000 | +33.0% | 71,529 | +0.1% | 0.03% | +6.7% |
Q1 2021 | $8,710,000 | +44.2% | 71,482 | +81.1% | 0.03% | +36.4% |
Q4 2020 | $6,042,000 | +84.8% | 39,467 | +1.0% | 0.02% | +37.5% |
Q3 2020 | $3,269,000 | +67.4% | 39,086 | +47.1% | 0.02% | +33.3% |
Q2 2020 | $1,953,000 | +275.6% | 26,580 | +116.6% | 0.01% | +200.0% |
Q1 2020 | $520,000 | -22.0% | 12,271 | +12.0% | 0.00% | 0.0% |
Q4 2019 | $667,000 | +75.5% | 10,954 | +18.2% | 0.00% | +33.3% |
Q3 2019 | $380,000 | – | 9,264 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |